3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Neoplasms
93
Breast Neoplasms
79
Lung Neoplasms
50
Prostatic Neoplasms
45
Colorectal Neoplasms
33
Carcinoma, Non-Small-Cell Lung
31
Pancreatic Neoplasms
29
Hematologic Neoplasms
22
Lymphoma
19
Brain Neoplasms
19
Stomach Neoplasms
17
Ovarian Neoplasms
17
Urinary Bladder Neoplasms
15
Multiple Myeloma
14
Melanoma
14
Liver Neoplasms
14
Leukemia, Myeloid, Acute
14
Head and Neck Neoplasms
13
Esophageal Neoplasms
13
Carcinoma, Hepatocellular
13
Uterine Cervical Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Non-Hodgkin
12
Leukemia
12
Disease
12
Carcinoma, Renal Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
11
Kidney Neoplasms
11
Colonic Neoplasms
11
Glioma
10
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
30 days
×
Clear all
NCT07395804
2026-05-29
23146
Bayer
Recruiting
500 enrolled
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled